Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy

Human Molecular Genetics
T C PanM C Speer

Abstract

The Bethlem myopathy is a rare autosomal dominant proximal myopathy characterized by early childhood onset and joint contractures. Evidence for linkage and genetic heterogeneity has been established, with the majority of families linked to 21q22.3 and one large family linked to 2q37, implicating the three type VI collagen subunit genes, COL6A1 (chromosome 21), COL6A2 (chromosome 21) and COL6A3 (chromosome 2) as candidate genes. Mutations of the invariant glycine residues in the triple-helical domain-coding region of COL6A1 and COL6A2 have been reported previously in the chromosome 21-linked families. We report here the identification of a G-->A mutation in the N-terminal globular domain-coding region of COL6A3 in a large American pedigree (19 affected, 12 unaffected), leading to the substitution of glycine by glutamic acid in the N2 motif, which is homologous to the type A domains of the von Willebrand factor. This mutation segregated to all affected family members, to no unaffected family members, and was not identified in 338 unrelated Caucasian control chromosomes. Thus mutations in either the triple-helical domain or the globular domain of type VI collagen appear to cause Bethlem myopathy.

Citations

Sep 26, 2000·Muscle & Nerve·R D Cohn, K P Campbell
Aug 17, 2001·Annals of Neurology·I HiguchiM Osame
Apr 5, 2002·Muscle & Nerve·Olga Camacho VanegasGuglielmina Pepe
Feb 20, 2002·Matrix Biology : Journal of the International Society for Matrix Biology·Erhard Hohenester, Jürgen Engel
Nov 18, 1998·Current Opinion in Cell Biology·J P Gorski, B R Olsen
Jun 6, 2003·Current Opinion in Genetics & Development·Isin Dalkilic, Louis M Kunkel
Jan 22, 2002·Neuromuscular Disorders : NMD·Guglielmina PepeAndoni Urtizberea
Jul 17, 1999·Neuromuscular Disorders : NMD·L MerliniN M Maraldi
Jan 20, 2005·Histopathology·D S Tews, H H Goebel
Sep 6, 2005·Journal of Medical Genetics·A K Lampe, K M D Bushby
May 16, 2012·Pediatrics·Benjamin D SolomonJames C Mullikin
Feb 13, 2014·Molecular Therapy. Nucleic Acids·Véronique BolducCarsten G Bönnemann
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·O Camacho VanegasG Pepe
Apr 8, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·A Reghan FoleyMichael G Hanna
Sep 20, 2005·Molecular and Cellular Neurosciences·Stefania PetriniEnrico Bertini
Sep 4, 2001·European Journal of Oral Sciences·M P LewisH L Tippett
Nov 1, 2009·Expert Opinion on Medical Diagnostics·Carmen Navarro, Susana Teijeira
Aug 8, 2015·Molecular Genetics & Genomic Medicine·Jesse M HunterLisa Baumbach-Reardon
Oct 11, 2001·Molecular Genetics and Metabolism·K F O'Brien, L M Kunkel
Mar 21, 2000·American Journal of Human Genetics·M BrockingtonF Muntoni
Jul 30, 2015·PloS One·Zlatko RadevFrédéric Sohm
Jul 13, 2005·Neuromuscular Disorders : NMD·Anna FidziańskaIrena Hausmanowa-Petrusewicz
Feb 24, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Benjamin H MullinScott G Wilson
Apr 29, 1999·Brain : a Journal of Neurology·G J JöbsisM de Visser
Sep 5, 2002·American Journal of Medical Genetics·Eileen P AhearnK Ranga Rama Krishnan
Feb 7, 2018·Muscle & Nerve·Soo Yeon KimJong-Hee Chae
Sep 22, 2007·Annals of Neurology·Naomi L BakerShireen R Lamandé
Jun 22, 2011·Nature Reviews. Neurology·Carsten G Bönnemann
Apr 20, 2001·Annals of Medicine·J Myllyharju, K I Kivirikko
Oct 1, 2008·Annals of Neurology·Rishika A PaceShireen R Lamandé
Oct 12, 2000·The Journal of Biological Chemistry·J FitzgeraldJ F Bateman
Apr 1, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T SasakiM L Chu
Sep 9, 1999·Acta Neurologica Scandinavica·K TanakaJ Kira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.